Tahir Latif practices Oncology. He studied medicine at Allama Iqbal Medical College. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Tahir Latif is a published doctor and has 13 publications published. The lastest was: 'Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib.' He is registered with Medicare.
NPI NUMBER | 1750378717 | |
NPPES Provider LastName | LATIF | |
NPPES Provider FirstName | TAHIR | |
NPPES Provider ZIPCode | 452194231 | |
NPPES Provider State | OH | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 685.0 | |
Distinct Opioid Count | 6.0 | |
Opioid Claim Count | 170.0 | |
Percent Opioid Claims | 24.82 |
National Provider Identifier [NPI] | 1750378717 |
Last Name Of The Provider | LATIF |
First Name Of The Provider | TAHIR |
View All |
Dr. Ehsan Malek, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Brian A. Mannion, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Elyse E. Lower, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Jamie K. Waselenko, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Gina M. Matacia, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Jason M. Jones, MD | |
Dr. Hamid Emamekhoo, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Nupam A. Patel, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Hooman Parsi, MD | |
Dr. Lori E. Crosby, PSY.D |